case_images: PMC6955121_01
case_images: CT scan showing left displaced malar fracture. Blue dots point areas where HA was injected deep to the bone.
case_images: CRIS2019-1360741.001.jpg
case_images: PMC6955121_01_CRIS2019-1360741.001.jpg
case_images: fig1
case_images: Only few weeks later, the patient noted facial asymmetry and a complete fracture of the zygomatic arch emerged after CT scan evaluation (Figure 1).
case_images: Preinjection marking.
case_images: CRIS2019-1360741.002.jpg
case_images: PMC6955121_01_CRIS2019-1360741.002.jpg
case_images: fig2
case_images: After a careful evaluation of the CT scan, we decided to inject sovra-periosteally in the injured area: 1 mL of VYC-20L (Juvederm Voluma with Lidocaine, Allergan plc, Dublin, Ireland) deep to the bone, 0.2 mL in the medial area, and 0.4 mL in two points in the lateral area (Figure 2); then, we used a cannula to restore the right malar projection injecting 1 mL of VYC-17L (Juvederm Volift with Lidocaine, Allergan plc, Dublin, Ireland) in the subcutaneous layer.
case_images: Preinjection and 2- and 5-month postinjection frontal view results.
case_images: CRIS2019-1360741.003.jpg
case_images: PMC6955121_01_CRIS2019-1360741.003.jpg
case_images: fig3
case_images: The patient was followed up for 1 year showing stable results for the first 8 months (Figures 3 and 4); at the 12-month follow-up, a touch-up was suggested due to partial resorption of the filler (Figure 5).
case_images: Preinjection and 2- and 5-month postinjection three-quarter left view results.
case_images: CRIS2019-1360741.004.jpg
case_images: PMC6955121_01_CRIS2019-1360741.004.jpg
case_images: fig4
case_images: The patient was followed up for 1 year showing stable results for the first 8 months (Figures 3 and 4); at the 12-month follow-up, a touch-up was suggested due to partial resorption of the filler (Figure 5).
case_images: Frontal and three-quarter left view results at the 12-month follow-up.
case_images: CRIS2019-1360741.005.jpg
case_images: PMC6955121_01_CRIS2019-1360741.005.jpg
case_images: fig5
case_images: The patient was followed up for 1 year showing stable results for the first 8 months (Figures 3 and 4); at the 12-month follow-up, a touch-up was suggested due to partial resorption of the filler (Figure 5).